This topic contains a solution. Click here to go to the answer

Author Question: The three levels of dysfunction that may be evaluated in a patient with an endocrine problem are ... (Read 124 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
The three levels of dysfunction that may be evaluated in a patient with an endocrine problem are primary, secondary, and tertiary.
 
  The possible defective sites that correspond to these primary, secondary, and tertiary levels of dysfunction are, respectively:
  A) Pituitary, target gland, hypothalamus
  B) Hypothalamus, target gland, pituitary
  C) Pituitary, hypothalamus, target gland
  D) Target gland, pituitary, hypothalamus
  E) Target gland, hypothalamus, pituitary

Question 2

Urinary aminolevulinic acid (ALA) levels are increased in all of the following disorders, except:
 
  A) Acute intermittent porphyria
  B) Coproporphyria
  C) Protoporphyria
  D) Variegate porphyria



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bdobbins

  • Sr. Member
  • ****
  • Posts: 326
Answer to Question 1

Ans: D

Answer to Question 2

Ans: C





 

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

The first-known contraceptive was crocodile dung, used in Egypt in 2000 BC. Condoms were also reportedly used, made of animal bladders or intestines.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library